DongKook Pharmaceutical’s Pansidil and Madecassol Rank No. 1 in Hair Loss and Wound Treatment Categories in 'Korea Brand Power Index'
DongKook Pharmaceutical announced on March 25 that its flagship over-the-counter (OTC) drugs, Pansidil and Madecassol, were named No. 1 in the hair loss treatment and wound treatment categories, respectively, in the ‘2026 Korea Brand Power Index’ survey conducted by Korea Management Association Consulting (KMAC). Pansidil secured the top position for the eighth consecutive year, while Madecassol ranked first for the fifth consecutive year, once again reinforcing their status as leading brands in their respective categories.
Pansidil achieved a Brand Power Index (K-BPI) score of 816.0 out of 1,000, maintaining a significant lead over the second-place brand. In particular, the brand’s high initial awareness rate of 64% reflects the result of consistent and continuous messaging about the product and a strong familiarity built over many years. Furthermore, Pansidil demonstrated strong brand competitiveness by recording high scores in all subcategories of brand loyalty, including image, purchase possibility, and preference.
Madecassol recorded a Brand Power Index (K-BPI) score of 732.2 out of 1,000, securing the No. 1 position in the wound and scar treatment category for the fifth consecutive year. The brand received particularly high and consistent evaluations in the brand loyalty category, which is attributed to consumers’ strong trust in TECA (Titrated Extract of Centella Asiatica), the plant-derived main ingredient in the Madecassol series.
Pansidil contains six ingredients optimized for hair and nail health, including keratin and L-cystine, which are essential components of hair and nails, as well as medicinal yeast and vitamins, which serve as hair nutrients. These ingredients are directly supplied to hair root cells through the bloodstream, helping to thicken hair and reduce hair loss. Madecassol’s main ingredient, the titrated extract of Centella Asiatica, supports the synthesis of collagen similar to that of normal skin in the wound healing process, thereby promoting the regeneration of new tissue. In addition, the Madecassol line offers a variety of products tailored to different wound types, such as Madecassol Care, Madecassol Gel, Complex Madecassol, Madecassol Powder, and Madecassol Moisture Band.
A marketing representative from DongKook Pharmaceutical stated, “The fact that Pansidil and Madecassol have been ranked No. 1 for several consecutive years in the authoritative KMAC Brand Power survey is the result of consistently earning consumers’ trust as the leading brands for hair loss and wound treatment. Building on these achievements, we will continue to run campaigns to promote the proven efficacy of our products and the importance of disease management, thereby enhancing our brand competitiveness and contributing to public health.”
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
Meanwhile, the ‘Korea Brand Power Index (K-BPI)’ is a brand evaluation index developed by Korea Management Association Consulting in 1999 for the first time in Korea. It is a system that certifies brands representing each sector of Korean consumer life.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.